Watermark

BGB-290-104

Completed

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-290-104

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2017

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan